Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance

Novartis

Status and phase: Completed; Phase 4

Conditions: Impaired Glucose Tolerance; Hypertension

Treatments: Drug: valsartan

Study type: Interventional

Funder types: Industry

Identifiers

NCT00241072

CVAL489A2412

Details and patient eligibility

About

THE PURPOSE OF THIS STUDY IS TO DETERMINE IF 24 WEEKS OF TREATMENT WITH VALSARTAN (80 MG - 320 MG) IMPROVES INSULIN SENSITIVITY IN SUBJECTS WITH HIGHER THAN NORMAL GLUCOSE LEVELS USING A TEST CALLED THE EUGLYCEMIC CLAMP.

Enrollment: 27 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

history or presenting hypertension Elevated fasting blood glucose levels -

Exclusion criteria

Pregnancy potential Diabetes mellitus

Other criteria apply

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)